|
FEZ2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.879600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.827800E-01 |
| Normal-vs-Stage2 |
2.001000E-01 |
| Normal-vs-Stage3 |
8.953800E-01 |
| Normal-vs-Stage4 |
5.304100E-02 |
| Stage1-vs-Stage2 |
2.132000E-01 |
| Stage1-vs-Stage3 |
7.183800E-01 |
| Stage1-vs-Stage4 |
9.329700E-02 |
| Stage2-vs-Stage3 |
1.727820E-01 |
| Stage2-vs-Stage4 |
7.859400E-01 |
| Stage3-vs-Stage4 |
6.711700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.620600E-01 |
| Normal-vs-AfricanAmerican |
4.842200E-01 |
| Normal-vs-Asian |
4.663800E-01 |
| Caucasian-vs-AfricanAmerican |
5.369800E-01 |
| Caucasian-vs-Asian |
5.041400E-01 |
| AfricanAmerican-vs-Asian |
2.807200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.087200E-01 |
| Normal-vs-Female |
6.669600E-01 |
| Male-vs-Female |
4.706000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.681400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.538200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.631800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.788400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.296400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.189800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.863800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.549760E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.354200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.762200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.915800E-01 |
| Classical-VS-Follicular |
2.162800050165E-09 |
| Classical-VS-Other |
1.076630E-01 |
| Classical-VS-Normal |
2.277600E-01 |
| Tall-VS-Follicular |
1.004390E-04 |
| Tall-VS-Other |
2.487800E-01 |
| Tall-VS-Normal |
2.442200E-01 |
| Follicular-VS-Other |
7.382600E-01 |
| Follicular-VS-Normal |
1.63460000000004E-05 |
| Other-VS-Normal |
3.959000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.719800E-02 |
| Normal-vs-N1 |
1.648200E-01 |
| N0-vs-N1 |
8.730400E-01 |
|
|
